Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)

Clinical trial NCT05769595 · COMPLETED

Trial details

NCT number: NCT05769595
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

End-Stage Renal Disease (ESRD)End-Stage Kidney Disease (ESKD)Kidney Failure, Chronic

Start date: 2023-06-14
Primary completion: 2024-02-15
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.